http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories
-
Absci and Twist Bioscience Collaborate to Design Novel Antibody using Generative AI
-
How A.I. Is Shaping the Future of U.S. Healthcare: Regulatory and Market Updates
-
Twist Bioscience (TWST) Launches IVDR-compliant Precision Dx Products
-
Twist Bioscience Launches IVDR-compliant Precision Dx Products for Whole Exome Sequencing
-
Twist Bioscience to Present at Upcoming Investor Conferences
-
Twist Bioscience (TWST) and Element Biosciences Collaborate on Exome Sequencing Solutions for AVITI System
-
Twist Bioscience and Element Biosciences Collaborate on Exome Sequencing Solutions for AVITI System
-
Twist Bioscience Corporation (TWST) Launches cfDNA Library Preparation Kit for Liquid Biopsy Applications
-
Twist Bioscience Launches cfDNA Library Preparation Kit for Liquid Biopsy Applications
-
Twist Bioscience Unveils Differentiated Ultra High-Throughput Library Preparation Solution at AGBT
-
Twist Bioscience Reports Fiscal First Quarter 2024 Financial Results
-
Twist Bioscience Corporation (TWST) Expands Express Genes Rapid Synthesis Service
-
Twist Bioscience Expands Express Genes Rapid Synthesis Service
-
Twist Bioscience to Report Fiscal 2024 First Quarter Financial Results on Friday, February 2, 2024
-
Twist Bioscience Corporation (TWST) Appoints Adam Laponis as CFO
-
Twist Bioscience Appoints Adam Laponis as Chief Financial Officer
-
Twist Bioscience to Present at 42nd Annual J.P. Morgan Healthcare Conference
-
Twist Bioscience Reports Fiscal Fourth Quarter and Full Year Fiscal 2023 Financial Results
-
Twist Bioscience Launches Express Genes Rapid Gene Synthesis Service
-
Twist Bioscience to Present at 6th Annual Evercore ISI HealthCONx Conference
-
Twist Bioscience to Report Fiscal 2023 Fourth Quarter and Full Year Financial Results on Friday, November 17, 2023
-
Twist Bioscience (TWST) Launches Full Length Unique Dual Index Adapters to Enable PCR-free Whole Genome Sequencing
-
Twist Bioscience Launches Full Length Unique Dual Index Adapters to Enable PCR-free Whole Genome Sequencing
-
Twist Bioscience (TWST) Enters into Antibody Discovery and Licensing Option Agreement with Bayer of up to $188 Million
-
Twist Bioscience Enters into Antibody Discovery and Licensing Option Agreement with Bayer of up to $188 Million
-
Twist Bioscience Appoints Mark Buck as Senior Vice President, Operations
-
Twist Bioscience Corporation (TWST) and IMIDomics Collaborate to Discover Antibodies for Applications in Immune-Mediated Inflammatory Diseases
-
Twist Bioscience and IMIDomics Collaborate to Discover Antibodies for Applications in Immune-Mediated Inflammatory Diseases
-
Twist Bioscience to Present at Upcoming Investor Conferences
-
Twist Bioscience Corporation (TWST) Enters Deal with Ono Pharmaceutical to Discover Novel Antibodies for Autoimmune Diseases
-
Twist Bioscience Enters into Agreement with Ono Pharmaceutical to Discover Novel Antibodies for Autoimmune Diseases
-
Twist Bioscience Releases 2023 ESG Report and Quantifies Carbon Footprint of Manufacturing a Single Gene
-
Twist Bioscience to Present at the UBS MedTech, Tools and Genomics Summit 2023
-
Twist Bioscience Reports Fiscal Third Quarter 2023 Financial Results
-
Twist Bioscience to Report Fiscal 2023 Third Quarter Financial Results on Friday, August 4, 2023
-
Twist Bioscience Corporation (TWST) and Cancer Research Horizons Enter into Collaboration to Advance Cancer Research
-
Twist Bioscience and Cancer Research Horizons Enter into Collaboration to Advance Cancer Research
-
Twist Bioscience Corporation (TWST) Publishes Preclinical Data in Diabetes Validating GLP-1R Antagonist Antibody as Potential Treatment for Congenital Hyperinsulinism
-
Twist Bioscience Publishes Preclinical Data in Diabetes Validating GLP-1R Antagonist Antibody as Potential Treatment for Congenital Hyperinsulinism
-
Twist Bioscience Corporation (TWST) Appoints Chet Gandhi as Chief Information Officer
-
Twist Bioscience Appoints Chet Gandhi as Chief Information Officer
-
Twist Bioscience Corporation (TWST) and CeGaT Launch RNA Fusion Panel to Advance Oncology and Precision Medicine Research
-
Twist Bioscience and CeGaT Launch RNA Fusion Panel to Advance Oncology and Precision Medicine Research
-
Twist Bioscience to Present at Upcoming Investor Conferences
-
Twist Bioscience Appoints Robert Werner as Chief Accounting Officer
-
Twist Bioscience Launches Portfolio of RNA Sequencing Tools
-
Twist Bioscience to Present at ITF World 2023
-
Twist Bioscience Reports Fiscal Second Quarter 2023 Financial Results
-
Twist Bioscience Corporation (TWST) and Aster Insights Partner on Launch of Next Generation Oncology Panel for Cancer Research
-
Twist Bioscience and Aster Insights Partner on Launch of Next Generation Oncology Panel for Cancer Research

